相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Comprehensive Analysis of Serum and Fecal Bile Acid Profiles and Interaction with Gut Microbiota in Primary Biliary Cholangitis
Weihua Chen et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2020)
Gut microbiome in primary sclerosing cholangitis: A review
Rebecca Little et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis
Lijun Liao et al.
GUT (2019)
Bile Acids as Metabolic Regulators and Nutrient Sensors
John Y. L. Chiang et al.
ANNUAL REVIEW OF NUTRITION, VOL 39, 2019 (2019)
The gut microbial influence on cholestatic liver disease
Martin Kummen et al.
LIVER INTERNATIONAL (2019)
Diverse Consequences in Liver Injury in Mice with Different Autophagy Functional Status Treated with Alcohol
Shengmin Yan et al.
AMERICAN JOURNAL OF PATHOLOGY (2019)
Biological Functions of Autophagy Genes: A Disease Perspective
Beth Levine et al.
CELL (2019)
Hepatic Autophagy Deficiency Compromises Farnesoid X Receptor Functionality and Causes Cholestatic Injury
Bilon Khambu et al.
HEPATOLOGY (2019)
Alcohol, liver disease and the gut microbiota
Jasmohan S. Bajaj
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Metabolic Messengers: fibroblast growth factor 15/19
Raffaella Maria Gadaleta et al.
NATURE METABOLISM (2019)
Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease
Christoph Grander et al.
GUT (2018)
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Wei Jia et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Alterations in Intestinal Microbiota Lead to Production of Interleukin 17 by Intrahepatic γδ T-Cell Receptor-Positive Cells and Pathogenesis of Cholestatic Liver Disease
Dana Tedesco et al.
GASTROENTEROLOGY (2018)
Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2(-/-) mice by modulating composition, signalling and excretion of faecal bile acids
Claudia Daniela Fuchs et al.
GUT (2018)
Fibroblast Growth Factor 15-Dependent and Bile Acid-Independent Promotion of Liver Regeneration in Mice
Bo Kong et al.
HEPATOLOGY (2018)
Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
Preeti Pathak et al.
HEPATOLOGY (2018)
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
Phillipp Hartmann et al.
HEPATOLOGY (2018)
Exploring new treatment paradigms for alcoholic hepatitis by extrapolating from NASH and cholestasis
Thoetchai (Bee) Peeraphatdit et al.
JOURNAL OF HEPATOLOGY (2018)
The gut-liver axis and the intersection with the microbiome
Anupriya Tripathi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis
Katharina Brandl et al.
JOURNAL OF HEPATOLOGY (2018)
Fibroblast growth factor 15/19 (FGF15/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration
Gloria Alvarez-Sola et al.
GUT (2017)
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice
Gladys Ferrere et al.
JOURNAL OF HEPATOLOGY (2017)
Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15
Mei Zhou et al.
JOURNAL OF HEPATOLOGY (2017)
Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice
Nobuhiro Nakamoto et al.
CELL REPORTS (2017)
Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts
Veronica Urdaneta et al.
FRONTIERS IN MEDICINE (2017)
Western Diet-Induced Dysbiosis in Farnesoid X Receptor Knockout Mice Causes Persistent Hepatic Inflammation after Antibiotic Treatment
Prasant K. Jena et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis
James H. Tabibian et al.
HEPATOLOGY (2016)
Engineered Fibroblast Growth Factor 19 Reduces Liver Injury and Resolves Sclerosing Cholangitis in Mdr2-Deficient Mice
Mei Zhou et al.
HEPATOLOGY (2016)
Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host Metabolism
Annika Wahlstrom et al.
CELL METABOLISM (2016)
Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD
Joao Sabino et al.
GUT (2016)
Bile acids as metabolic regulators
Tiangang Li et al.
CURRENT OPINION IN GASTROENTEROLOGY (2015)
Bile Acids as Hormones: The FXR-FGF15/19 Pathway
Steven A. Kliewer et al.
DIGESTIVE DISEASES (2015)
Dysbiosis-Induced Intestinal Inflammation Activates Tumor Necrosis Factor Receptor I and Mediates Alcoholic Liver Disease in Mice
Peng Chen et al.
HEPATOLOGY (2015)
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
Margit Hagel et al.
CANCER DISCOVERY (2015)
Fibroblast growth factor 15 deficiency impairs liver regeneration in mice
Bo Kong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2014)
Interactions Between the Intestinal Microbiome and Liver Diseases
Bernd Schnabl et al.
GASTROENTEROLOGY (2014)
Dysbiosis Contributes to Fibrogenesis in the Course of Chronic Liver Injury in Mice
Samuele De Minicis et al.
HEPATOLOGY (2014)
Nrf2 promotes the development of fibrosis and tumorigenesis in mice with defective hepatic autophagy
Hong-Min Ni et al.
JOURNAL OF HEPATOLOGY (2014)
A nontumorigenic variant of FGF19 treats cholestatic liver diseases
Jian Luo et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Gut Microbiota Regulates Bile Acid Metabolism by Reducing the Levels of Tauro-beta-muricholic Acid, a Naturally Occurring FXR Antagonist
Sama I. Sayin et al.
CELL METABOLISM (2013)
Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice
Iker Uriarte et al.
GUT (2013)
Bile acid sequestrants: more than simple resins
Carolien Out et al.
CURRENT OPINION IN LIPIDOLOGY (2012)
Host-Gut Microbiota Metabolic Interactions
Jeremy K. Nicholson et al.
SCIENCE (2012)
Autophagy-deficient mice develop multiple liver tumors
Akito Takamura et al.
GENES & DEVELOPMENT (2011)
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1
Masaaki Komatsu et al.
NATURE CELL BIOLOGY (2010)
Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice
Masaaki Komatsu et al.
CELL (2007)
Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man
T. Lundasen et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy
DJ Kennedy et al.
HYPERTENSION (2006)
Bile salt biotransformations by human intestinal bacteria
JM Ridlon et al.
JOURNAL OF LIPID RESEARCH (2006)
分享论文
